XML 20 R6.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Shareholders' Equity
$ in Thousands
USD ($)
shares
Issued and Outstanding Shares
USD ($)
shares
Additional paid-in capital
USD ($)
Accumulated other comprehensive income (loss)
USD ($)
Accumulated deficit
USD ($)
Number of shares outstanding at beginning of period (in shares) at Mar. 31, 2020 | shares   92,206,817      
Equity at beginning of period at Mar. 31, 2020 $ 344,138 $ 852,115 $ 11,773 $ (6,271) $ (513,479)
Net loss (124,278)       (124,278)
Issuance of shares upon public offerings (in shares) | shares   19,756,196      
Issuance of shares upon public offerings 952,534 $ 952,534      
Share issuance costs $ (44,702) $ (44,702)      
Exercise of stock options and settlement of share awards (in shares) | shares 2,951,034 3,038,643      
Exercise of stock options and settlement of share awards $ 21,008 $ 29,643 (8,635)    
Share-based compensation 32,739   32,739    
Share-based acquisition-related compensation (in shares) | shares   194,042      
Share-based acquisition-related compensation 4,518 $ 4,518      
Shares issued in connection with business combination (in shares) | shares   13,332,817      
Shares issued in connection with business combination 690,788 $ 690,788      
Replacement awards issued in connection with business combination 40,432 40,432      
Share-based compensation impact from replacement awards issued in connection with business combination 1,120 $ 1,120      
Other comprehensive loss 15,986     15,986  
Number of shares outstanding at end of period (in shares) at Mar. 31, 2021 | shares   128,528,515      
Equity at end of the period at Mar. 31, 2021 1,934,283 $ 2,526,448 35,877 9,715 (637,757)
Net loss (288,433)       (288,433)
Issuance of shares upon public offerings (in shares) | shares   8,855,000      
Issuance of shares upon public offerings 823,515 $ 823,515      
Share issuance costs $ (33,984) $ (33,984)      
Exercise of stock options and settlement of share awards (in shares) | shares 1,061,359 1,332,218      
Exercise of stock options and settlement of share awards $ 17,494 $ 38,510 (21,016)    
Share-based compensation 108,916   108,916    
Share-based acquisition-related compensation (in shares) | shares   638,323      
Share-based acquisition-related compensation 45,042 $ 45,042      
Shares issued in connection with business combination (in shares) | shares   9,307,256      
Shares issued in connection with business combination 799,494 $ 799,494      
Other comprehensive loss (7,038)     (7,038)  
Number of shares outstanding at end of period (in shares) at Mar. 31, 2022 | shares   148,661,312      
Equity at end of the period at Mar. 31, 2022 $ 3,399,289 $ 4,199,025 $ 123,777 $ 2,677 $ (926,190)